Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance category
|
| gptkbp:abusePotential |
Moderate to low
|
| gptkbp:comparedToScheduleII |
Lower abuse potential
|
| gptkbp:comparedToScheduleIV |
Higher abuse potential
|
| gptkbp:controlledBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:definedIn |
gptkb:United_States_Controlled_Substances_Act
|
| gptkbp:equivalentTo |
Schedule III (INCB)
|
| gptkbp:example |
gptkb:Anabolic_steroids
gptkb:Buprenorphine gptkb:Ketamine gptkb:Testosterone gptkb:Tylenol_with_codeine |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule III substances
|
| gptkbp:legalStatus |
Prescription only
|
| gptkbp:medicalUse |
gptkb:Accepted
|
| gptkbp:prescriptionRefills |
Up to 5 times in 6 months
|
| gptkbp:regulationYear |
1970
|
| gptkbp:scheduleNumber |
III
|
| gptkbp:bfsParent |
gptkb:21_U.S.C._§_812
gptkb:21_U.S.C._§_841 gptkb:21_U.S._Code_§_829 gptkb:21_U.S._Code_§_841 |
| gptkbp:bfsLayer |
7
|